ANAB - AnaptysBio Inc logo

ANAB

AnaptysBio Inc

AnaptysBio, Inc. develops immunology therapeutics for autoimmune and inflammatory diseases. Its pipeline includes candidates like Rosnilimab for rheumatoid arthritis and Imsidolimab for psoriasis, targeted toward both U.S. patients and clinical trials.

⚕️ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 5 years ago $3,590today

Score Overview

1 Year
Score
Net Growth-102.44%
Net TrendShrank
Net Income Consistency
Rev Growth-0.94%
Rev TrendShrank
Revenue Consistency
5 Years
Score5.1
Net Growth53.65%
Net Trend40%
Net Income Consistency
Rev Growth267.85%
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth10.92%
Net Trend33%
Net Income Consistency
Rev Growth23x
Rev Trend56%
Revenue Consistency

See the full market ranking →

AnaptysBio Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 75M to $ 234M and net income went from -$ 19M to -$ 13M. Revenue increased in 3 of those 5 years; net income in 2.

Across AnaptysBio Inc's full reported history, from 2017 to 2025, revenue grew from $ 10M to $ 234M and net income went from -$ 30M to -$ 13M. Revenue increased in 56% of the years measured; net income in 33%.

AnaptysBio Inc currently holds a 5-year HDB Score of 5.1 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 56.98
1 Year2025-08-12
$ 13.41325.01%
5 Years2021-08-12
$ 15.87258.97%
All Time2017-01-26
$ 11.33402.77%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 232M-$ 26M$ 286M
2025$ 234M-$ 13M$ 311M
2024$ 91M-$ 145M$ 385M
2023$ 17M-$ 163M$ 390M
2022$ 10M-$ 128M$ 441M
2021$ 63M-$ 57M$ 548M
2020$ 75M-$ 19M$ 393M
2019$ 8M-$ 97M$ 374M
2018$ 5M-$ 61M$ 427M
IPO2017$ 10M-$ 30M$ 248M

Explore beyond ANAB

You're looking at AnaptysBio Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies